BBIO

BRIDGEBIO PHARMA INC

BBIO·10806X102·US·Common Stock·Healthcare - Biotechnology-Activist

BBIO (BRIDGEBIO PHARMA INC) is held by 208 institutional investors as of Q2 2026. Largest holders: FARALLON CAPITAL MANAGEMENT, L.L.C. ($800.1M), BlackRock, Inc. ($766.2M), VIKING GLOBAL INVESTORS LP ($741M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 109 funds bought BBIO.

208
Holders
(16 Elite)
$10.7B
Total Value
51% (213)
Consensus
109 buying - 104 selling
13F: Insider & Congress: Updated regularly
BBIO

Smart Money Verdict

View all
Loading verdict
Held by 208 funds
16 elite

Who's Trading

Source dates: Price Aug 31, 2026 · Insiders Aug 20, 2026 · Activists Aug 17, 2026 · Congress Jun 8, 2026

InsiderKNKumar NeilSell $679KAug 19, 2026
InsiderKNKumar NeilSell $152KAug 19, 2026
InsiderKNKumar NeilSell $9KAug 19, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
10.7M(+14.7%)$800.1M3.7%+76.93%
67
Decreased
10.3M(-27.6%)$766.2M0.0%+162.89%
0
Decreased
9.9M(-16.0%)$741M2.1%+184.02%
0
Increased
7.9M(+1.8%)$588.3M0.0%+3.15%
32
Decreased
7.7M(-5.3%)$570.3M0.0%+3.15%
0
Increased
5.3M(+113.7%)$395.4M0.1%+8.83%
50
Increased
4.7M(+51.3%)$351.7M0.3%+28.62%
52
Decreased
4.4M(-10.1%)$330.4M0.0%+100.60%
0
Increased
3.8M(+18.5%)$280M0.0%+2.53%
36
Decreased
3.7M(-19.4%)$275.6M0.0%+68.76%
0
Increased
3.6M(+42.7%)$270.6M0.1%+37.78%
49
Decreased
3.4M(-30.5%)$254.7M0.0%+76.87%
0
Increased
2.9M(+66.9%)$218.5M0.0%+10.51%
45
Increased
2.4M(+82.7%)$173.2M0.0%+15.61%
47
Increased
2.3M(+276.0%)$167.7M0.2%+12.87%
59
Decreased
2.2M(-11.4%)$160.9M0.0%+33.14%
0
Decreased
2.1M(-18.1%)$153.7M0.4%+16.32%
0
Decreased
2.1M(-12.1%)$153.5M0.0%+78.63%
0
Decreased
2M(-1.1%)$145.7M0.1%+165.13%
0
Unchanged
1.9M$138.6M0.4%+184.02%
0

Showing 1-20 of 224

1 / 12
BBIOBBIOBRIDGEBIO PHARMA INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used